miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer

(2013) Y Shen et al.   BRITISH JOURNAL OF CANCER

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer

(2013) J H Huh et al.   BRITISH JOURNAL OF CANCER

RNAi Therapeutics and Applications of MicroRNAs in Cancer Treatment

(2013) Keita Uchino et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma through Targeting Caveolin-2 Involved in Focal Adhesion Pathway

(2013) Takeshi Yamasaki et al.   JOURNAL OF UROLOGY

BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling

(2013) M Sung et al.   ONCOGENE

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

(2012) Martin Puhr et al.   AMERICAN JOURNAL OF PATHOLOGY

Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell

(2012) Ning Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells

(2012) V. Kovaleva et al.   CANCER RESEARCH

MicroRNAs: Novel mediators of resistance to microtubule-targeting agents

(2012) Arun Kanakkanthara et al.   CANCER TREATMENT REVIEWS

Microtubule Plus-End Tracking Proteins SLAIN1/2 and ch-TOG Promote Axonal Development

(2012) B. van der Vaart et al.   JOURNAL OF NEUROSCIENCE

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

(2012) K Boll et al.   ONCOGENE

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

(2011) A Holleman et al.   ONCOGENE

Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells

(2010) Guo-hai Shi et al.   ACTA PHARMACOLOGICA SINICA

Caspase-8 as a therapeutic target in cancer

(2010) Dwayne G. Stupack   CANCER LETTERS

MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance

(2010) Yuemeng Dai et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression

(2010) Yasunori Fujita et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Microtubule-binding agents: a dynamic field of cancer therapeutics

(2010) Charles Dumontet et al.   NATURE REVIEWS DRUG DISCOVERY

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

(2010) Keitaro Kojima et al.   PROSTATE

Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules

(2009) A Mielgo et al.   ONCOGENE

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

(2008) Yasunori Fujita et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype

(2008) S E Elsheikh et al.   BRITISH JOURNAL OF CANCER

Role of microRNAs in drug-resistant ovarian cancer cells

(2008) Antonio Sorrentino et al.   GYNECOLOGIC ONCOLOGY